Molecular Imaging and Therapy Research Unit (MIT)
หน่วยวิจัยโมเลกุลาร์อิมเมจจิงแอนด์เทอราปี (ESPRel no. 2-0040-0101-1)Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, 50200, Thailand
At the Molecular Imaging and Therapy (MIT) research unit, our mission is to lead the frontier in the Discovery, Research, and Development of Molecules for Innovation in Imaging and Therapy. We are committed to advancing scientific knowledge and pioneering breakthroughs that redefine the landscape of molecular imaging and therapeutic interventions. Our dedicated team strives to unravel the complexities of non-communicable diseases, with a particular focus on cancer, diabetes, cerebrovascular disorders, and brain and neurodegenerative diseases.
We aim to revolutionize diagnostic imaging and therapeutic modalities through meticulous discovery processes, cutting-edge research methodologies, and the development of novel molecules. Our mission extends beyond traditional boundaries, incorporating the rich pharmacological potential of Thai plants, extracts, and purified polyphenols. By combining ancient botanical wisdom with modern medical science, we seek to enhance the efficacy of conventional chemotherapy and radiotherapy.
In our relentless pursuit of innovation, we actively design, synthesize, and develop molecular imaging probes and theranostic agents. These agents hold the promise of transforming not only how we diagnose diseases but also how we approach their treatment. Additionally, our commitment extends to synthesizing metal complexes, exemplified by creations like Iron-Quercetin, serving as cutting-edge MRI contrast agents and facilitating stem cell tracking for advanced therapeutic applications.
Through our unwavering dedication to Discovery, Research, and Development, the MIT research unit aspires to catalyze positive change in healthcare. We envision a future where our innovative molecules redefine standards, offering new hope and improved patient outcomes worldwide.
